Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
about
Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapyAlzheimer's Disease associated with Psychiatric ComorbiditiesTargeted lipidomics - advances in profiling lysophosphocholine and platelet-activating factor second messengersAblation of Ca(V)2.1 voltage-gated Ca²⁺ channels in mouse forebrain generates multiple cognitive impairmentsDefects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's diseaseBuying time: a rationale for examining the use of circadian rhythm and sleep interventions to delay progression of mild cognitive impairment to Alzheimer's diseaseNonhuman primate models of Alzheimer-like cerebral proteopathyUsing neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease.Early behavioral changes and quantitative analysis of neuropathological features in murine prion disease: stereological analysis in the albino Swiss mice model.Ligand-based and structure-based investigation for Alzheimer's disease from traditional chinese medicine.NOX activity is increased in mild cognitive impairmentβ-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation.LRRK2 function on actin and microtubule dynamics in Parkinson diseaseRole of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1.The protein oxidation repair enzyme methionine sulfoxide reductase a modulates Aβ aggregation and toxicity in vivo.Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's diseaseThe contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesisThe renaissance of Ca2+-binding proteins in the nervous system: secretagogin takes center stage.Presynaptic active zones in invertebrates and vertebrates.Plasma microRNA biomarkers for detection of mild cognitive impairment.Monoacylglycerol lipase is a therapeutic target for Alzheimer's diseaseAmitriptyline protects against TNF-α-induced atrophy and reduction in synaptic markers via a Trk-dependent mechanismOpposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation.Scorpion Venom Heat-Resistant Peptide Protects Transgenic Caenorhabditis elegans from β-Amyloid Toxicity.Multiple effects of β-amyloid on single excitatory synaptic connections in the PFC.Phenserine efficacy in Alzheimer's disease.Characterization of age-related changes in synaptic transmission onto F344 rat basal forebrain cholinergic neurons using a reduced synaptic preparationBasic mechanisms of neurodegeneration: a critical update.Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary NeuronsAlzheimer's disease and tauopathy studies in flies and worms.The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease.Hippocampal synaptic activity, pattern separation and episodic-like memory: implications for mouse models of Alzheimer's disease pathology.Relationship between genetic risk factors and markers for Alzheimer's disease pathology.Calcium channel blockers and dementia.Molecular biomarkers of neurodegeneration.Dantrolene, a treatment for Alzheimer disease?"Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.Neuronal Network Oscillations in Neurodegenerative Diseases.Intra-axonal protein synthesis in development and beyond.
P2860
Q26382049-D182492F-6C6A-4E42-B5E0-1BA346D96E18Q26796602-7608C7EC-A538-4F10-A135-43FE1A6E04BDQ27008183-95B221BE-2EED-4B31-BC3D-9780AEC69770Q27303054-81DDC1CA-B1F2-4D64-9AE9-F91E9C37F27DQ27307877-5C5B1C18-6CF0-46C5-BD7F-D6F284A11338Q28383805-77BBA362-65A8-4A5B-B346-2E75E982DE52Q28728135-DEAA0DFA-EDAA-4DFD-AAF0-06063A45B795Q30451918-0CCF6696-389C-45B8-BD4F-DCFD59E39601Q30466255-81E767BA-AE37-4C65-BA73-0202763EA254Q33668480-4B2DE0D2-B064-4E6B-907E-BCC42F99F27FQ33830110-DD5C1F02-8613-46A1-A1C6-00EF8AC4018EQ34268487-118CB68F-EB6A-4D84-8BCD-D1102E160F0AQ34280111-DC65B17E-6C80-4A99-B5CE-BD2711F3855CQ34299079-A9A72AD9-600C-4FAE-9BA0-8BE6EB99FE78Q34729853-5AE60C2D-1321-4ECE-A68E-7D827A192E7DQ35359220-17A37EE1-C1EB-4632-A02F-18A6740F0262Q35549855-FC6735E3-006F-4159-97AD-1F70B33DD343Q35613257-E8EC23A8-BE62-43BF-B457-842CFD9DEBFEQ36004250-7B7E0D3C-D11C-41D8-B598-74AE9C81A29CQ36380583-AE5E7964-2230-4241-A5C8-6A33CF5BC4D5Q36442881-E1B8A46B-413B-48E6-9338-D5B0B0CE0FB7Q36719650-5DFFFFB3-88E2-4CB8-8595-CD3DE41C7E30Q36873059-A5E054D4-50A1-4711-BB64-4DC2D5B95F20Q37124409-F2DA10EA-9B31-492D-9743-641B4E61D01BQ37138837-E9CD913F-892E-4203-AEA6-239F04D946A9Q37510264-373F5D3A-1901-42F0-BA27-BD9CA2D57C16Q37578342-98917F92-0029-4C84-A5DF-68800696D702Q37673274-5C4DEE4D-01EF-4066-BD92-781CD5620FF7Q37699616-A67370CA-5A2C-46E0-AB37-386B0E000C23Q37715058-9CDB3604-3019-4E8F-8033-8BAFFD088F35Q37774042-98DE9028-57CA-443F-91D8-BD42BBAE6385Q37863247-B7F0CFE9-C965-451E-BE08-0638E7CE0FA1Q37905125-A881F43E-329D-456E-A8C4-565123651650Q38037159-3EF43A55-A078-4CAC-995A-D80C21AFCF35Q38103603-AE28635D-DFB7-4311-9A1B-846D37DC1805Q38154930-A857CEBF-CE27-4A33-AA38-92717C2AB190Q38304771-ADD679DE-5173-41D3-9D1B-9268A2CCAC37Q38441500-EA656E42-864F-4060-B46B-CAADE0CAE1CCQ38446620-B8A14821-66E8-4F0A-8C50-96F649FF946CQ38771285-6B5591A0-678C-451B-8273-543742885C66
P2860
Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is Alzheimer's disease a resul ...... ed by oligomeric beta-amyloid.
@en
Is Alzheimer's disease a resul ...... ed by oligomeric beta-amyloid.
@nl
type
label
Is Alzheimer's disease a resul ...... ed by oligomeric beta-amyloid.
@en
Is Alzheimer's disease a resul ...... ed by oligomeric beta-amyloid.
@nl
prefLabel
Is Alzheimer's disease a resul ...... ed by oligomeric beta-amyloid.
@en
Is Alzheimer's disease a resul ...... ed by oligomeric beta-amyloid.
@nl
P2860
P1476
Is Alzheimer's disease a resul ...... ed by oligomeric beta-amyloid.
@en
P2093
Ulrich Ebert
Volker Nimmrich
P2860
P356
10.1515/REVNEURO.2009.20.1.1
P577
2009-01-01T00:00:00Z